A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer.
BMC Cancer., 12(1):449 (2012)
Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: A case report and review of the literature.
Head Neck., Sep (2012)
The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement.
J Natl Compr Canc Netw., May;10(5):599-613 (2012)
Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer.
J. Clin. Oncol., Nov;28(33):4953-60 (2010)
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.
Clin. Cancer Res., Nov;16(21):5260-8 (2010)
Maintenance chemotherapy in non-small cell lung cancer.
J Natl Compr Canc Netw., Jul;8(7):815-21 (2010)
Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
Int. J. Radiat. Oncol. Biol. Phys., Nov;78(3):696-702 (2010)
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer.
Ann. Oncol., Mar;21(3):556-61 (2010)
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.
J. Clin. Oncol., Aug;27(23):3794-801 (2009)
Thymic carcinoma associated with paraneoplastic polymyositis.
J. Clin. Oncol., Aug;27(22):e33-4 (2009)
Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.
Ann. Thorac. Surg., Nov;86(5):1632-8; discussion 1638-9 (2008)
Phase I trial of erlotinib combined with cisplatin and radiotherapy for patients with locally advanced cervical squamous cell cancer.
Clin. Cancer Res., Oct;14(19):6324-9 (2008)
18F FDG-PET/CT findings in recurrent respiratory papillomatosis.
Ann Nucl Med., Jun;22(5):433-6 (2008)
Motesanib diphosphate in progressive differentiated thyroid cancer.
N. Engl. J. Med., Jul;359(1):31-42 (2008)
Second-line and third-line chemotherapy for lung cancer: use and cost.
Am J Manag Care., May;14(5):297-306 (2008)
First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.
J. Clin. Oncol., May;26(15):2442-9 (2008)
Response to paclitaxel in adenoid cystic carcinoma of the salivary glands.
Head Neck., Jun;30(6):810-4 (2008)
Antagonism of platelet-derived growth factor receptor in non small cell lung cancer: rationale and investigations.
Clin. Cancer Res., Aug;13(15 Pt 2):s4632-6 (2007)
Novel agents in the treatment of lung cancer: Fourth Cambridge Conference.
Clin. Cancer Res., Aug;13(15 Pt 2):s4583-8 (2007)
Treatment of recurrent squamous cell carcinoma of the skin with cetuximab.
Arch Dermatol., Jul;143(7):889-92 (2007)
Phase II trial of neoadjuvant chemotherapy using alternating doublets in non-small-cell lung cancer.
Clin Lung Cancer., Jan;8(4):257-63 (2007)
Medullary thyroid cancer: options for systemic therapy of metastatic disease?
J. Clin. Oncol., Apr;24(11):1653-5 (2006)
Treatment of locally advanced non-small cell lung cancer with combination of chemotherapy and radiation.
Semin Respir Crit Care Med., Jun;26(3):273-7 (2005)